DNLI: Denali Therapeutics Inc. Stock

by  •  • Comments Off on DNLI: Denali Therapeutics Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,815.19
Enterprise Value ($M) 1,640.23
Book Value ($M) 1,229.68
Book Value / Share 8.47
Price / Book 1.48
NCAV ($M) 719.94
NCAV / Share 4.96
Price / NCAV 2.52

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.27
Return on Equity (ROE) -0.29

Liquidity (mrq)
Quick Ratio 8.46
Current Ratio 8.46

Balance Sheet (mrq) ($M)
Current Assets 864.44
Assets 1,374.18
Liabilities 144.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -501.88
Net Income -422.77
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -347.69
Cash from Investing -88.76
Cash from Financing 484.30

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Capital Research Global Investors 3.80 -30.75
02-12 13G/A Baillie Gifford & Co 7.20 -80.79
11-12 13G/A Fmr Llc 7.08 41.02
11-08 13G/A Wellington Management Group Llp 7.49 47.46
11-08 13G/A BlackRock, Inc. 9.60 0.00
11-07 13G/A Biogen Inc. 4.97 -43.89

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 296,966 1,137,599 26.10
2025-04-10 300,589 1,066,165 28.19
2025-04-09 460,714 1,863,822 24.72
2025-04-08 686,195 2,151,217 31.90
2025-04-07 239,263 1,524,685 15.69

(click for more detail)

Similar Companies
CTMX – CytomX Therapeutics, Inc. CYTK – Cytokinetics, Incorporated
DAWN – Day One Biopharmaceuticals, Inc. DSGN – Design Therapeutics, Inc.
DVAX – Dynavax Technologies Corporation


Financial data and stock pages provided by
Fintel.io